Paris, France

Jean-Jacques Panthier


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012-2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Innovations of Jean-Jacques Panthier: A Trailblazer in Melanoma Research**

Introduction

Jean-Jacques Panthier, an esteemed inventor based in Paris, France, has made significant contributions to the field of melanoma research. With three patents to his name, he has focused on the detection and diagnosis of melanoma through innovative methodologies.

Latest Patents

Among his latest patents, "Upregulation of RACK-1 in melanoma and its use as a marker" stands out. This invention pertains to a method for diagnosing melanoma in mammals, focusing on the detection of the overexpression of the RACK-1 protein in melanocyte cells. The presence of melanoma can be determined by this overexpression of RACK-1 protein. Additionally, he has developed a method for assessing the tumoral status of melanocyte cells, allowing for a clearer understanding of the cancerous state of the cells based on the same protein overexpression.

Career Highlights

Jean-Jacques Panthier has made his mark through his work with renowned institutions such as Institut Pasteur and Institut Curie. His research has been pivotal in advancing techniques for early detection and diagnostic methods for melanoma, thus enhancing patient outcomes in oncology.

Collaborations

Throughout his career, Panthier has collaborated with several noteworthy individuals, including Giorgia Egidy and Xavier Sastre-Garau. These collaborations have fostered innovative research and development in the field of cancer diagnostics.

Conclusion

In conclusion, Jean-Jacques Panthier’s contributions to melanoma research through his inventive methods and patents demonstrate a profound impact on the field. His work not only exemplifies innovation but also holds great promise for the future of cancer detection and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…